Protective effect of a polyvalent influenza DNA vaccine in pigs

Ingrid Karlsson, Marie Borggren, Maiken Worsøe Rosenstierne, Ramona Trebbien, James A. Williams, Enric Vidal, Júlia Vergara-Alert, David Solanes Foz, Ayub Darji, Marta Sisteré-Oró, Joaquim Segalés, Jens Nielsen, Anders Fomsgaard

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)


© 2017 The Authors Background Influenza A virus in swine herds represents a major problem for the swine industry and poses a constant threat for the emergence of novel pandemic viruses and the development of more effective influenza vaccines for pigs is desired. By optimizing the vector backbone and using a needle-free delivery method, we have recently demonstrated a polyvalent influenza DNA vaccine that induces a broad immune response, including both humoral and cellular immunity. Objectives To investigate the protection of our polyvalent influenza DNA vaccine approach in a pig challenge study. Methods By intradermal needle-free delivery to the skin, we immunized pigs with two different doses (500 μg and 800 μg) of an influenza DNA vaccine based on six genes of pandemic origin, including internally expressed matrix and nucleoprotein and externally expressed hemagglutinin and neuraminidase as previously demonstrated. Two weeks following immunization, the pigs were challenged with the 2009 pandemic H1N1 virus. Results When challenged with 2009 pandemic H1N1, 0/5 vaccinated pigs (800 μg DNA) became infected whereas 5/5 unvaccinated control pigs were infected. The pigs vaccinated with the low dose (500 μg DNA) were only partially protected. The DNA vaccine elicited binding-, hemagglutination inhibitory (HI) − as well as cross-reactive neutralizing antibody activity and neuraminidase inhibiting antibodies in the immunized pigs, in a dose-dependent manner. Conclusion The present data, together with the previously demonstrated immunogenicity of our influenza DNA vaccine, indicate that naked DNA vaccine technology provides a strong approach for the development of improved pig vaccines, applying realistic low doses of DNA and a convenient delivery method for mass vaccination.
Original languageEnglish
Pages (from-to)25-32
JournalVeterinary Immunology and Immunopathology
Publication statusPublished - 1 Jan 2018


  • Challenge
  • DNA vaccine
  • H1N1pdm09
  • Needle-free immunization
  • Protection
  • Swine influenza

Fingerprint Dive into the research topics of 'Protective effect of a polyvalent influenza DNA vaccine in pigs'. Together they form a unique fingerprint.

Cite this